Type 2 Diabetes

Diabetes and Renal Outcomes: Reduced Progression of Kidney Disease With Liraglutide Tx

Diabetes and Renal Outcomes: Reduced Progression of Kidney Disease With Liraglutide Tx

Liraglutide plus usual care resulted in lower rates of diabetic kidney disease-specific outcomes in type 2 diabetes.

Managing Type 2 Diabetes: The Impact of Secure Patient-Provider Messaging

Managing Type 2 Diabetes: The Impact of Secure Patient-Provider Messaging

By

Secure messaging presents an opportunity for patients and healthcare providers to collaborate on self-management issues like glycemic control, diet, and exercise.

In-Hospital Tramadol Use Increases Hypoglycemia Risk in T1D, T2D

In-Hospital Tramadol Use Increases Hypoglycemia Risk in T1D, T2D

Results indicate that blood glucose monitoring should be conducted in hospitalized patients with diabetes.

Predicting Rapid Reduction in Renal Function Using Plasma Biomarkers

Predicting Rapid Reduction in Renal Function Using Plasma Biomarkers

Researchers identified several novel plasma biomarkers that can be used to predict rapid decline in renal function in T2D, independent of traditional risk factors.

Diabetes Self-Management Class Participation Varies in Adults with T2D

Diabetes Self-Management Class Participation Varies in Adults with T2D

Clinicians should identify barriers to patient participation in diabetes self-management classes.

Examining Inclusion of T2D Medication Adherence Data in Studies

Examining Inclusion of T2D Medication Adherence Data in Studies

Results suggest that medication adherence is associated with reduced risk of all-cause mortality in T2D.

Predicting Adult MetS, T2D, CV Risks in Childhood

Predicting Adult MetS, T2D, CV Risks in Childhood

By

BMI measurement alone can also be used to determine associations between childhood and adulthood conditions.

Reducing ED Visits, Hospital use With T2D Risk Assessment Tool

Reducing ED Visits, Hospital use With T2D Risk Assessment Tool

By

Validation-tool identified "high risk" patients were more likely to report hypoglycemia episodes and subsequent emergence department use.

Addressing Psychological Insulin Resistance in Patients With Diabetes

Addressing Psychological Insulin Resistance in Patients With Diabetes

By

Learn about strategies to reduce a patient's reluctance to initiate insulin therapy, a phenomenon called psychological insulin resistance.

Glucagon Response to Hypoglycemia Altered in Diabetes Secondary to Chronic Pancreatitis

Glucagon Response to Hypoglycemia Altered in Diabetes Secondary to Chronic Pancreatitis

Patients with type 2 diabetes and those with diabetes secondary to chronic pancreatitis have similarly impaired α-cell responses to oral glucose ingestion and hypoglycemia.

No Fingerstick Necessary: FDA Approves Novel Continuous Glucose Monitoring System for Diabetes

No Fingerstick Necessary: FDA Approves Novel Continuous Glucose Monitoring System for Diabetes

By

New monitoring system involves the placement of a small sensor wire beneath the skin surface to continuously monitor glucose levels.

Poorly Controlled Rheumatoid Arthritis Increases T2D Risk

Poorly Controlled Rheumatoid Arthritis Increases T2D Risk

Type 2 diabetes is significantly underdiagnosed and undertreated in patients with rheumatoid arthritis.

Predicting Coronary Artery Events in T2D With Imaging Plus Risk Factor Assessment

Predicting Coronary Artery Events in T2D With Imaging Plus Risk Factor Assessment

By

Patients with MACE showed a greater extent of more severe coronary artery disease.

Fatty Acid Remodeling Common in T2D Following Bariatric Surgery

Fatty Acid Remodeling Common in T2D Following Bariatric Surgery

Researchers examined how adipocyte size reduction and fatty acid metabolism contribute to remission in type 2 diabetes following bariatric surgery.

Reducing HbA1c in T2D: Efficacy of Immune-Modulator Anti-Inflammatory Treatments

Reducing HbA1c in T2D: Efficacy of Immune-Modulator Anti-Inflammatory Treatments

Diacerein was well-tolerated among trial participants, and may be an acceptable adjunct treatment in type 2 diabetes.

Counseling vs Standard Care to Increase Physical Activity in T2D

Counseling vs Standard Care to Increase Physical Activity in T2D

Three hundred physically inactive or sedentary patients received either theoretical and practical counseling once-yearly for 3 years, or standard care.

Inverse Relationship Between Sleep Duration and Risk of T2D in Children

Inverse Relationship Between Sleep Duration and Risk of T2D in Children

Researchers identified strong inverse graded relationships between children's sleep duration, adiposity, and the presence of diabetes risk markers.

Lowering Heart Failure Hospitalizations in T2D: SGLT2 vs DPP4 Inhibitors

Lowering Heart Failure Hospitalizations in T2D: SGLT2 vs DPP4 Inhibitors

By

A retrospective analysis examined outcomes in patients with type 2 diabetes treated with SGLT2 vs DPP4 inhibitors.

Can Sustained Weight Loss Lead to Remission of T2D?

Can Sustained Weight Loss Lead to Remission of T2D?

Weight loss in people with type 2 diabetes is associated with extended life expectancy.

Atrial Fibrillation With Diabetes: Risk for Cardiovascular Events in Women vs Men

Atrial Fibrillation With Diabetes: Risk for Cardiovascular Events in Women vs Men

By

Women with atrial fibrillation and diabetes had a higher risk for mortality and cardiovascular complications compared with men.

Type 2 Diabetes Weight Regain Not Prevented With Group CBT

Type 2 Diabetes Weight Regain Not Prevented With Group CBT

By

Researchers examined the efficacy of cognitive behavioral group therapy on preventing weight regain or modifying cardiovascular risk factors and psychological well-being.

Examining Cold-Related Cardiorespiratory Symptoms in T2D

Examining Cold-Related Cardiorespiratory Symptoms in T2D

By

Worsening glycemic status is linked to increased reports of individual cardiorespiratory symptoms, including dyspnea, cough, chest pain, and arrythmia.

Does PCOS Increase T2D Event Rate?

Does PCOS Increase T2D Event Rate?

Among women with polycystic ovary syndrome, type two diabetes was more common and diagnosed at a younger age than in control groups.

Increasing Glycemic Control With Continuous Glucose Monitoring in T2D

Increasing Glycemic Control With Continuous Glucose Monitoring in T2D

Study results support an additional management method for glycemic control in patients with T2D.

How Does Lifestyle Intervention Benefit Glycemic Control in T2D?

How Does Lifestyle Intervention Benefit Glycemic Control in T2D?

By

Researchers examined the efficacy of lifestyle intervention on glycemic control in type 2 diabetes.

Predicting Emergency Department or Hospital Visits in T2D Adverse Events

Predicting Emergency Department or Hospital Visits in T2D Adverse Events

By

Over 150 variables were identified as possible hypoglycemia risk factors.

Type 2 Diabetes and Antidepressant Drug Use: Is There a Causal Link?

Type 2 Diabetes and Antidepressant Drug Use: Is There a Causal Link?

By

Updated meta-analysis confirms the association between antidepressant drug (AD) use and incident diabetes. Future studies should be aimed at evaluating the effect of single AD on the risk of developing T2D.

Treatment Delays in T2D Increase Cardiovascular Biomarkers

Treatment Delays in T2D Increase Cardiovascular Biomarkers

Serum NT-proBNP and serum hsTnl levels were examined at baseline, 26, 52, and 104 weeks.

Ipragliflozin vs Pioglitazone for NAFLD in T2D

Ipragliflozin vs Pioglitazone for NAFLD in T2D

Ipragliflozin showed "equally beneficial effects" on glycemic control in patients with nonalcoholic fatty liver disease and type 2 diabetes.

GSK Announces Discontinuation of Injectable Therapy for T2D

GSK Announces Discontinuation of Injectable Therapy for T2D

By

GlaxoSmithKline expects Tanzeum supplies to be depleted by July 2018.

Sign Up for Free e-Newsletters